However, MHYs appear to be incompatible to the colon cancer with RAS mutations because MHYs suppressed the growth of colon cancer cells with only wild-type KRAS (Fig. 1b and Supplementary Fig. 1). Here, KRAS is linked to malignant colon neoplasm.